左束支区域起搏与双心室起搏在再同步治疗适应患者中的比较
该多中心观察性研究纳入1778例LVEF≤35%且符合CRT I/II类适应症的患者,比较左束支区域起搏(LBBAP)与双心室起搏(BVP)的临床结局。结果显示LBBAP起搏QRS更窄,LVEF改善更显著,主要复合终点(死亡或心衰住院)风险显著低于BVP。
要点
- LBBAP起搏QRS时限显著窄于BVP(128±19 ms vs 144±23 ms,P<0.001)。
- LBBAP的LVEF改善幅度显著大于BVP(13%±12% vs 10%±12%,P<0.001)。
- LBBAP主要终点(死亡或心衰住院)风险显著低于BVP(HR 1.495,95%CI 1.213-1.842)。
核心结论
- 在符合CRT适应症的患者中,LBBAP相比BVP可改善临床结局,可能作为BVP的合理替代方案。
研究设计与样本
- 国际15中心观察性研究,纳入2018年1月至2022年6月首次因CRT I类或II类适应症接受BVP或LBBAP且LVEF≤35%的患者,共1778例(BVP 981例,LBBAP 797例)。
主要发现
- LBBAP起搏QRS时限128±19 ms,显著窄于基线161±28 ms(P<0.001),也显著窄于BVP的144±23 ms(P<0.001)。
- LBBAP组LVEF从27%±6%提升至41%±13%(P<0.001),BVP组从27%±7%提升至37%±12%(P<0.001),LBBAP较基线的改善幅度显著更大(13%±12% vs 10%±12%,P<0.001)。
- 多变量回归分析显示,LBBAP主要终点(死亡或心衰住院)发生率20.8%,BVP为28%,LBBAP风险显著降低(HR 1.495,95%CI 1.213-1.842,P<0.001)。
临床怎么用
- 对于LVEF≤35%且符合CRT适应症的患者,LBBAP可考虑作为BVP的替代起搏策略,以进一步改善左室功能并降低死亡或心衰住院风险。
局限性
- 本研究为观察性设计,非随机对照,可能存在选择偏倚和未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac resynchronization therapy (CRT) with biventricular pacing (BVP) is a well established therapy in patients with reduced left ventricular ejection fraction (LVEF), heart failure, and wide QRS or expected frequent ventricular pacing. Left bundle branch area pacing (LBBAP) has recently been shown to be a safe alternative to BVP. OBJECTIVES: The aim of this study was to compare the clinical outcomes between BVP and LBBAP among patients undergoing CRT. METHODS: This observational study included patients with LVEF ≤35% who underwent BVP or LBBAP for the first time for Class I or II indications for CRT from January 2018 to June 2022 at 15 international centers. The primary outcome was the composite endpoint of time to death or heart failure hospitalization (HFH). Secondary outcomes included endpoints of death, HFH, and echocardiographic changes. RESULTS: A total of 1,778 patients met inclusion criteria: 981 BVP, 797 LBBAP. The mean age was 69 ± 12 years, 32% were female, 48% had coronary artery disease, and mean LVEF was 27% ± 6%. Paced QRS duration in LBBAP was significantly narrower than baseline (128 ± 19 ms vs 161 ± 28 ms; P < 0.001) and significantly narrower compared to BVP (144 ± 23 ms; P < 0.001). Following CRT, LVEF improved from 27% ± 6% to 41% ± 13% (P < 0.001) with LBBAP compared with an increase from 27% ± 7% to 37% ± 12% (P < 0.001) with BVP, with significantly greater change from baseline with LBBAP (13% ± 12% vs 10% ± 12%; P < 0.001). On multivariable regression analysis, the primary outcome was significantly reduced with LBBAP compared with BVP (20.8% vs 28%; HR: 1.495; 95% CI: 1.213-1.842; P < 0.001). CONCLUSIONS: LBBAP improved clinical outcomes compared with BVP in patients with CRT indications and may be a reasonable alternative to BVP.
引用
- Vijayaraman P, Sharma PS, Cano Ó, et al. Comparison of Left Bundle Branch Area Pacing and Biventricular Pacing in Candidates for Resynchronization Therapy. J Am Coll Cardiol. 2023. PMID: 37220862. doi:10.1016/j.jacc.2023.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。